Abhishek Shukla of HSBC initiated coverage of CoreWeave in a research note Thursday, issuing a $32 price target and a Reduce rating—HSBC’s equivalent of Sell—citing elevated cost forecasts and few options for diversification. That $32 figure implies a 77% drop from Wednesday’s closing price and the lowest target among analysts polled by FactSet.

CoreWeave had an exciting H1'25 performance, thanks to the IPO, the demand for its neocloud, and the consequently rich multi-year backlog. Read why CRWV is a compelling buy.

CoreWeave's $6 billion investment in Pennsylvania suggests there could be vast promise for AI data centers in a state already leading in energy production.

The stock closed up 6.2% on the news. CoreWeave has been seeing scorching-hot growth since it pivoted its business model to AI infrastructure, providing computing capacity to companies like Microsoft, Nvidia, and OpenAI, and it needs new data centers to fuel that growth.

CoreWeave and Core Scientific are both down sharply since agreeing to merge.

CoreWeave will unveil the project at a CEO roundtable with Trump during an Energy and Innovation Summit at Carnegie Mellon University.

C3.ai ( AI 3.98%) and CoreWeave ( CRWV 1.17%) are both poised to profit from the expansion of the artificial intelligence (AI) market. C3 develops AI algorithms and standalone modules that can be plugged into an organization's existing software infrastructure. CoreWeave's data centers provide cloud-based GPUs for processing AI tasks.

CoreWeave will buy crypto miner Core Scientific in an all-stock deal valued at about $9 billion, it said on Monday, as AI infrastructure firms race to secure the energy and data center capacity needed to power surging demand.

CoreWeave acquires Core Scientific for strategic AI alignment, $10bn lease savings, but high leverage risks remain. See why I rate CRWV stock a Buy now.